Wearable polygraph detects hidden stress
May 13, 2026
The body can notice stress before the conscious brain — and that’s no lie
The body can notice stress before the conscious brain — and that’s no lie
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.
Epineuron announced today that it received FDA 510(k) clearance for its Evala nerve stimulator technology.
Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical partners, have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A new way to detect the onset of heart and kidney disease far earlier than previously possible has been discovered by scientists. The breakthrough, published today in Nature Communications, reveals a novel method for identifying damage to the lining of microscopic blood vessels.
Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, which aims to bring high-resolution, real-time diagnostics directly to the point of care, was recently described in a paper published in the Proceedings of the National Academy of Sciences.
Now, a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that targets a protein found almost exclusively on leukemia cells and not on healthy cells.
Researchers at Washington University School of Medicine in St. Louis, showed that a stem cell transplant in which the donor cells have been genetically engineered to remove a particular protein helps prevent toxic side effects and potentially improves the effectiveness of therapies given after a transplant to help prevent cancer recurrence.
The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to achieve this milestone.
Siemens Healthineers announced today that the FDA cleared six new systems within its Artis interventional imaging portfolio.